Previous close | 11.69 |
Open | 12.00 |
Bid | 11.97 x 400 |
Ask | 12.07 x 300 |
Day's range | 11.59 - 12.60 |
52-week range | 3.35 - 16.40 |
Volume | |
Avg. volume | 1,273,550 |
Market cap | 626.452M |
Beta (5Y monthly) | 0.76 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Axsome (AXSM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stoke Therapeutics (STOK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stoke Therapeutics (STOK) gains on meaningful clinical data from STK-001 studies for the treatment of Dravet syndrome.